MediSapiens Lands $1M in Seed Backing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Personalized medicine software company MediSapiens has raised $1 million in seed funding from Veraventure, ETF III, VTT Ventures, and Lifeline Ventures.

The Helsinki-based company provides a software database platform that provides genomic data about cancer and cancer treatments that can be used to develop personalized therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.